DBV Technologies | Vermögenswerte





Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Amarin USD 659.81M 10.31M 2025-09
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
DBV Technologies USD 110.49M 32.93M 2025-09
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Insmed USD 2.36B 119.12M 2025-09
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
PTC Therapeutics USD 2.64B 9.54M 2025-09
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Ultragenyx Pharmaceutical USD 1.19B 115.82M 2025-09
United Therapeutics USD 7.35B 556.9M 2025-09


DBV Technologies Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.